The authors reply

New England Journal of Medicine

Volumn 369, Issue 13, 2013, Pages 1280-

  Major, Eugene O ^a   Frohman, Elliot ^b   Douek, Daniel ^c  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NATALIZUMAB; VIRUS DNA; MONOCLONAL ANTIBODY;

ANTIBODY RESPONSE; BLOOD SAMPLING; HUMAN; IMMUNOASSAY; JC VIRUS; LETTER; MULTIPLE SCLEROSIS; PREVALENCE; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; SEROLOGY; VIREMIA; VIRUS INFECTION; ISOLATION AND PURIFICATION; NOTE; POLYOMAVIRUS INFECTION;

ANTIBODIES, MONOCLONAL, HUMANIZED; HUMANS; JC VIRUS; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; MULTIPLE SCLEROSIS; POLYOMAVIRUS INFECTIONS;

EID: 84884520682     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1308784     Document Type: Letter

References (2)

1. Berger JR, Houff SA, Gurwell J, Vega N, Miller CS, Danaher RJ. JC virus antibody status underestimates infection rates. Ann Neurol 2013 March 22 (Epub ahead of print).
2. Ryschkewitsch CF, Jensen PN, Major EO. Multiplex qPCR assay for ultra sensitive detection of JCV DNA with simultaneous identification of genotypes that discriminates non-virulent from virulent variants. J Clin Virol 2013;57:243-8.